+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Mo1004 Predictors and Durability of Biochemical Response to Ursodeoxycholic Acid (Udca) in Patients With Primary Biliary Cirrhosis (Pbc): A Long-Term Follow-Up Study



Mo1004 Predictors and Durability of Biochemical Response to Ursodeoxycholic Acid (Udca) in Patients With Primary Biliary Cirrhosis (Pbc): A Long-Term Follow-Up Study



Gastroenterology 148(4): S-1061




Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 067079075

Download citation: RISBibTeXText

DOI: 10.1016/s0016-5085(15)33623-4


Related references

Excellent long-term survival in patients with primary biliary cirrhosis and biochemical response to ursodeoxycholic Acid. Gastroenterology 130(3): 715-720, 2006

Biochemical response to ursodeoxycholic acid predicts long-term outcome in Japanese patients with primary biliary cirrhosis. Hepatology Research 41(4): 310-317, 2011

Biochemical response to ursodeoxycholic acid and long-term prognosis in primary biliary cirrhosis. Hepatology 48(3): 871-877, 2008

Different response to ursodeoxycholic acid udca in primary biliary cirrhosis pbc. Journal of Hepatology 16(Suppl. 1): S68, 1992

Early biochemical response to ursodeoxycholic acid and long-term prognosis of primary biliary cirrhosis: results of a 14-year cohort study. Hepatology 58(1): 264-272, 2013

Prognostic factors and long-term effects of ursodeoxycholic acid on liver biochemical parameters in patients with primary biliary cirrhosis. Journal of Hepatology 31(2): 256-262, 1999

Different response to ursodeoxycholic acid (UDCA) in primary biliary cirrhosis according to severity of disease. Digestive Diseases and Sciences 39(1): 9-14, 1994

Combined ursodeoxycholic acid (UDCA) and fenofibrate in primary biliary cholangitis patients with incomplete UDCA response may improve outcomes. Alimentary Pharmacology and Therapeutics 43(2): 283-293, 2016

Ursodeoxycholic acid in late primary biliary cirrhosis long term follow up. Gut 32(10): A1251, 1991

Changes induced by ursodeoxycholic acid udca administration on biliary and serum bile acid composition in patients with primary biliary cirrhosis pbc. Hepatology 12(4 Part 2): 995, 1990

Long term ursodeoxycholic acid treatment for primary biliary cirrhosis A 12 year follow up. Gut 53(Suppl 3): A84, 2004

Long-term ursodeoxycholic acid therapy for primary biliary cirrhosis: a follow-up to 12 years. Alimentary Pharmacology & Therapeutics 21(3): 217-226, 2005

Ursodeoxycholic acid udca influences immune parameters in patients with primary biliary cirrhosis pbc. Hepatology 12(4 Part 2): 957, 1990

Biochemical responses to bezafibrate improve long-term outcome in asymptomatic patients with primary biliary cirrhosis refractory to UDCA. Journal of Gastroenterology 50(6): 675-682, 2015

Influence of ursodeoxycholic acid udca on bile acid metabolism of patients with primary biliary cirrhosis pbc. Gastroenterology 98(5 Part 2): A590, 1990